ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,000 | +140.0% | 209 | +74.2% | 0.00% | – |
| Q2 2021 | $15,000 | -6.2% | 120 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | +14.3% | 120 | +6.2% | 0.00% | – |
| Q4 2020 | $14,000 | -63.2% | 113 | -66.6% | 0.00% | – |
| Q3 2020 | $38,000 | +40.7% | 338 | +12.7% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $27,000 | +68.8% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | +23.1% | 300 | -8.8% | 0.00% | – |
| Q3 2019 | $13,000 | -7.1% | 329 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | -6.7% | 329 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +36.4% | 329 | +31.6% | 0.00% | – |
| Q4 2018 | $11,000 | -21.4% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 250 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +20.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |